Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -9.57% is 93% above its 4-year average of -144.63%, near the high end of its 4-year range (-1962.62%–-3.90%).
As of the fiscal period ended Tuesday, June 30, 2026. 97.78% above its 12-month average of -430.68%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -9.57%.
RETURN ON INVESTED CAPITAL (ROIC)
-9.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-430.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-168.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+97.78%
CURRENT VS 3Y AVG
+94.31%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-27.25%
median of 439 covered companies
CURRENT VS SECTOR MEDIAN
+64.88%
vs the sector median at left
Canton Strategic Holdings Inc
Market Cap
$179.70M
Return on Invested Capital (ROIC)
-9.57%
TTM Avg
-430.68%
3Y Avg
-168.13%
5Y Avg
N/A
Market Cap
$176.96M
Return on Invested Capital (ROIC)
-1039.56%
TTM Avg
-137.05%
3Y Avg
-111.74%
5Y Avg
-93.55%
Market Cap
$184.12M
Return on Invested Capital (ROIC)
-5.22%
TTM Avg
-22.12%
3Y Avg
-29.09%
5Y Avg
-27.39%
Market Cap
$174.17M
Return on Invested Capital (ROIC)
-30.23%
TTM Avg
-28.70%
3Y Avg
-31.34%
5Y Avg
-41.69%
Market Cap
$173.04M
Return on Invested Capital (ROIC)
-135.38%
TTM Avg
-110.80%
3Y Avg
-91.23%
5Y Avg
-65.73%
Market Cap
$172.99M
Return on Invested Capital (ROIC)
-46.59%
TTM Avg
-39.23%
3Y Avg
-33.74%
5Y Avg
-53.74%
Market Cap
$192.97M
Return on Invested Capital (ROIC)
-74.02%
TTM Avg
-48.91%
3Y Avg
-62.69%
5Y Avg
-47.07%
Market Cap
$162.82M
Return on Invested Capital (ROIC)
-56.53%
TTM Avg
-185.89%
3Y Avg
-125.01%
5Y Avg
-88.85%
Market Cap
$160.82M
Return on Invested Capital (ROIC)
-13.94%
TTM Avg
-16.11%
3Y Avg
-25.11%
5Y Avg
-17.04%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canton Strategic Holdings Inc (CNTN) | $179.70M | -9.57% | -430.68% | -168.13% | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $176.96M | -1039.56% | -137.05% | -111.74% | -93.55% |
| Journey Medical Corporation (DERM)vs › | $184.12M | -5.22% | -22.12% | -29.09% | -27.39% |
| Precision BioSciences, Inc. (DTIL)vs › | $174.17M | -30.23% | -28.70% | -31.34% | -41.69% |
| Coherus Oncology, Inc. (CHRS)vs › | $173.04M | -135.38% | -110.80% | -91.23% | -65.73% |
| Compass Therapeutics, Inc. (CMPX)vs › | $172.99M | -46.59% | -39.23% | -33.74% | -53.74% |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $192.97M | -74.02% | -48.91% | -62.69% | -47.07% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $162.82M | -56.53% | -185.89% | -125.01% | -88.85% |
| Inogen, Inc. (INGN)vs › | $160.82M | -13.94% | -16.11% | -25.11% | -17.04% |
| AN2 Therapeutics, Inc. (ANTX)vs › | $202.05M | -51.01% | -69.12% | -59.60% | -89.29% |
ROIC
-9.6%
ROE
-21.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -9.57% |
| 2026-03-31 | -9.33% |
| 2025-12-31 | -3.90% |
| 2025-09-30 | -167.98% |
| 2025-06-30 | -1962.62% |
| 2024-12-31 | -950.86% |
| 2024-09-30 | -368.43% |
| 2024-06-30 | -135.90% |
| 2024-03-31 | -123.37% |
| 2023-12-31 | -103.55% |
| 2023-09-30 | -494.64% |
| 2023-06-30 | -264.60% |
| 2023-03-31 | -219.24% |
| 2022-12-31 | -124.14% |
| 2022-09-30 | -73.89% |
| 2022-06-30 | -40.62% |
| 2022-03-31 | -30.30% |
